The results showed that NAFLD patients with genotype GG of rs2896019 had significantly higher LDL (P < 0.001), ALT (P = 0.003), and AST (P = 0.002). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.